I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 31 studies | 30% ± 12% | |
| classical monocyte | 24 studies | 39% ± 16% | |
| non-classical monocyte | 23 studies | 44% ± 14% | |
| conventional dendritic cell | 22 studies | 30% ± 14% | |
| monocyte | 20 studies | 30% ± 7% | |
| plasmacytoid dendritic cell | 19 studies | 38% ± 12% | |
| natural killer cell | 17 studies | 21% ± 5% | |
| dendritic cell | 14 studies | 32% ± 16% | |
| myeloid cell | 14 studies | 32% ± 15% | |
| CD16-positive, CD56-dim natural killer cell, human | 11 studies | 27% ± 7% | |
| B cell | 8 studies | 22% ± 7% | |
| alveolar macrophage | 8 studies | 28% ± 10% | |
| memory B cell | 8 studies | 19% ± 4% | |
| mononuclear phagocyte | 5 studies | 36% ± 13% | |
| plasma cell | 5 studies | 23% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 19% ± 3% | |
| neutrophil | 4 studies | 22% ± 5% | |
| microglial cell | 4 studies | 19% ± 3% | |
| plasmablast | 3 studies | 29% ± 6% | |
| tissue-resident macrophage | 3 studies | 32% ± 13% | |
| intermediate monocyte | 3 studies | 56% ± 19% |
